According to Ovid Therapeutics 's latest financial reports the company's current EPS (TTM) is -$1.00. In 2022 the company made an earnings per share (EPS) of -$1.10 a decrease over its 2021 EPS that were of $2.52.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$0.94 | -13.72% |
2022 | -$1.10 | -143.5% |
2021 | $2.52 | -226.43% |
2020 | -$1.99 | -11.39% |
2019 | -$2.25 | -25.47% |
2018 | -$3.02 | -23.94% |
2017 | -$3.96 | 143.74% |
2016 | -$1.63 |